Short report n. 5 - In vitro test for the evaluation of individual risk of metastasis in surgically treated women for breast cancer

MammaPrint® [2011]
Descrizione/Abstract:

MammaPrint® is a genetic test designed to predict individual risk of recurence in patients with breast cancer. 

In vitro of genes in a sample of surgically removed breast of women treated for breast cancer. The test is used to predict individual risk of classifies the patients in two categories: low and high risk of metastasis test, based on a microarray methodology, that measures the level of activitydeveloping metastasis. The test classifies the patients in two categories: low and high risk of metastasis. 

 

Data di pubblicazione:
01/11/2011
Tipo di pubblicazione:
rapporti, linee guida, documenti tecnici
Lingua della pubblicazione:
Inglese
Scarica la pubblicazione:
download (PDF, 0.19 MB)

Valuta il sito

Non hai trovato quello che cerchi ?

Piè di pagina